[1]宋爱英,杨丹,曹德胜,等.平调饮对原发性肝癌患者AFPmRNA、MAGE-1mRNA表达的影响[J].中国中医药信息杂志,2010,17(7):17-19.[doi:10.3969/j.issn.1005-5304.2010.07.008]
 SONG Ai-ying,YANG Dan,CAO De-sheng,et al.Effect of Pingtiaoyin on Expression of AFPmRNA and MAGE-1mRNA in Hepatocellular Carcinoma Patients[J].zhongguo zhongyiyao xinxi zazhi,2010,17(7):17-19.[doi:10.3969/j.issn.1005-5304.2010.07.008]
点击复制

平调饮对原发性肝癌患者AFPmRNA、MAGE-1mRNA表达的影响

参考文献/References:

[1] Parkin DM, Bray F, Feday J, et a1. Global cancer statistics, 2002[J]. CA Cancer J Clin,2005,55(2):74-108.

[2] 中国抗癌协会肝癌专业委员会.原发性肝癌诊断标准[J].中华肝脏病杂志,2000,8(3):135.

[3] De Plaen E, Arden K, Traversari C, et al. Structure chromosomal localization, and expression of 12 genes of the MAGE family[J]. Immunogenetids,1994,40(5):360-369.

[4] Chen HS, Cai SL, Wang Y, et al. Expression of the MAGE-1 gene in human hepatocellular carcinomas[J]. Chin Med J,2000,113:1112-1118.

[5] 蔡胜利,赵海涛,冷希圣,等.黑色素瘤抗原-3基因在肝细胞癌中的研究[J].中华外科杂志,2000,38:693-696.

[6] Reed DS, Romero P, Rimoldi D, et al. Construction and characterization of a recombinant adenovirus direction expression of the MAGE-1 tumor specific antigen[J]. Int J Cancer,1997,72:1045-1055.

[7] Yamashita N, Ishibashi H, Hayashida k, et a1. High frequency of the MAGE-1 gene expression in hepatocellular carcinoma[J]. Hepatology,1996,24(6):1437-1440.

[8] Matsumura M, Niwa Y, Hikiba Y, et al. Sensitive assay for detection of hepatocellular carcinoma associated gene transcription (alpha-fetoprotein mRNA) in blood[J]. Biochem Biophys Res Commun,1995,207(2):813-818.

相似文献/References:

[1]迟惠昌,胡凤山,韩冬,等.疏肝健脾中药配合化学药物动脉灌注治疗中晚期原发性肝癌疗效观察[J].中国中医药信息杂志,2010,17(6):16.[doi:10.3969/j.issn.1005-5304.2010.06.008]
 CHI Hui-chang,HU Feng-shan,HAN Dong,et al.The Effectiveness of Liver-soothing and Spleen-strengthening Traditional Chinese Medicine Combined with Intra-arterial Infusion of Chemical Medicine for Advanced Primary Hepatocellular Cancer Patients[J].zhongguo zhongyiyao xinxi zazhi,2010,17(7):16.[doi:10.3969/j.issn.1005-5304.2010.06.008]
[2]胡兵,安红梅,沈克平.肝肾阴虚是原发性肝癌的发病基础[J].中国中医药信息杂志,2009,16(2):93.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(7):93.
[3]董海涛,赵炜,卢雯平,等.华蟾素并肝动脉介入治疗原发性肝癌38例临床观察[J].中国中医药信息杂志,2008,15(3):66.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(7):66.
[4]闫向勇,燕忠生,孟庆常,等.中医药配合肝动脉化疗栓塞治疗中晚期原发性肝癌疗效观察[J].中国中医药信息杂志,2008,15(11):71.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(7):71.
[5]马晔琳,陈良良.岩舒注射液联合肝动脉栓塞化疗治疗原发性肝癌系统评价[J].中国中医药信息杂志,2011,18(7):29.[doi:10.3969/j.issn.1005-5304.2011.07.011]
 MA Ye-lin,CHEN Liang-liang.Systematic Review on Yanshu Injection Plus TACE for Primary Liver Cancer[J].zhongguo zhongyiyao xinxi zazhi,2011,18(7):29.[doi:10.3969/j.issn.1005-5304.2011.07.011]
[6]赵增虎,杜欣,刘秀芳,等.肝动脉化疗栓塞结合健脾理气中药治疗中晚期肝癌临床研究[J].中国中医药信息杂志,2006,13(1):62.
 [J].zhongguo zhongyiyao xinxi zazhi,2006,13(7):62.
[7]刘丽坤,王晞星.原发性肝癌重症并发症治验[J].中国中医药信息杂志,2006,13(5):81.
 [J].zhongguo zhongyiyao xinxi zazhi,2006,13(7):81.
[8]贺用和,韩静.中药制剂在原发性肝癌肝动脉化疗栓塞术治疗中的应用研究进展[J].中国中医药信息杂志,2006,13(12):95.
[9]孙丽红.参灵合剂对H22肝癌小鼠抑瘤及免疫调节的影响[J].中国中医药信息杂志,2012,19(7):44.[doi:10.3969/j.issn.1005-5304.2012.07.017]
 SUN Li-hong.Tumor-suppressing and Immunoregulation Effect on H22 Hepatocarcinoma Mice of Mixture of Panaxoside, Ganoderma Lucidum Polysaccharides Extract and Barbed Skullcap Herb Polysaccharides[J].zhongguo zhongyiyao xinxi zazhi,2012,19(7):44.[doi:10.3969/j.issn.1005-5304.2012.07.017]
[10]杨素芳,林永廉.基于聚类分析的原发性肝癌介入治疗前中医证型特点研究[J].中国中医药信息杂志,2012,19(10):11.[doi:10.3969/j.issn.1005-5304.2012.10.005]
 YANG Su-fang,LIN Yong-lian.TCM Syndrome of Primary Liver Carcinoma before Interventional Treatment by Cluster Analysis[J].zhongguo zhongyiyao xinxi zazhi,2012,19(7):11.[doi:10.3969/j.issn.1005-5304.2012.10.005]

更新日期/Last Update: